HIGH-RISK RECTAL CANCER NEO-ADJUVANT CAPECITABINE AND OXALIPLATIN BEFORE RADIOTHERAPY WITH CONCOMITANT CAPECITABINE AND RADICAL SURGERY LOCOREGIONAL RESPONSE

被引：0
|
作者：
Brodmann, S. [1 ]
Bateman, A. C.
Bateman, A. [1 ]
机构：
[1] Southampton Gen Hosp, Radiotherapy Ctr, Southampton, Hants, England
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2010年 / 186卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：724 / 725
页数：2
相关论文
共 50 条
  • [41] CONCURRENT NEO-ADJUVANT CHEMO-RADIOTHERAPY USING CAPECITABINE AND SPHINCTER SPARING BY TRANS-ANAL ABDOMINALLY ASSISTED COLONIC PULL-THOUGH IN LOCALLY ADVANCED RECTAL CANCER
    Hamza, Hesham
    Shehata, Samer
    Khalaf, Marwa
    ANNALS OF ONCOLOGY, 2012, 23 : 115 - 115
  • [42] Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancer
    Salazar, Ramon
    Navarro, Matilde
    Losa, Ferran
    Alonso, Vicente
    Gallen, Manel
    Rivera, Fernando
    Benavides, Manuel
    Escudero, Pilar
    Gonzalez, Encarnacion
    Massuti, Bartomeu
    Gomez, Auxiliadora
    Majem, Margarita
    Aranda, Enrique
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (08): : 592 - 598
  • [43] Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Response to the local treatment after chemoradiation and surgery as secondary endpoint
    Schmoll, H. J.
    Haustermans, K.
    Price, T.
    Nordlinger, B.
    Hofheinz, R. D.
    Daisne, J. F.
    Janssens, J.
    Schmidt, P.
    Reinel, H.
    Van Cutsem, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S482 - S482
  • [44] CONCOMITANT ADJUVANT CHEMOTHERAPY AND RADIOTHERAPY FOR HIGH-RISK BREAST-CANCER PATIENTS
    HANSEN, R
    ERICKSON, B
    KOMAKI, R
    JANJAN, N
    COX, J
    WILSON, JF
    ANDERSON, T
    BREAST CANCER RESEARCH AND TREATMENT, 1991, 17 (03) : 171 - 177
  • [45] A phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer
    Brigette, Ma
    Janet, Lee
    Michael, Cheung
    Simon, Chu
    Dennis, Ng
    Leung, Li
    Carmen, Cho
    Esther, Hung
    William, Yeung
    Macy, Tong
    Wing, Ho
    Edwin, Hui
    Wai, Tsang
    Sophie, Hon
    Tony, Mak
    Simon, Ng
    Joyce, Suen
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Longer Interval Between Completion of Neo-Adjuvant Chemoradiotherapy and Surgery for Rectal Cancer Determines Complete Histopathological Response
    Arhi, C.
    Van Dellen, J.
    Brady, J.
    Yiu, C.
    Gaya, A.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 23 - 23
  • [47] Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy
    Cecchin, E.
    Agostini, M.
    Pucciarelli, S.
    De Paoli, A.
    Canzonieri, V.
    Sigon, R.
    De Mattia, E.
    Friso, M. L.
    Biason, P.
    Visentin, M.
    Nitti, D.
    Toffoli, G.
    PHARMACOGENOMICS JOURNAL, 2011, 11 (03): : 214 - 226
  • [48] Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy
    E Cecchin
    M Agostini
    S Pucciarelli
    A De Paoli
    V Canzonieri
    R Sigon
    E De Mattia
    M L Friso
    P Biason
    M Visentin
    D Nitti
    G Toffoli
    The Pharmacogenomics Journal, 2011, 11 : 214 - 226
  • [49] Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study
    Eisterer, Wolfgang
    Piringer, Gudrun
    De Vries, Alexander
    Oefner, Dietmar
    Greil, Richard
    Tschmelitsch, Joerg
    Samonigg, Hellmut
    Soelkner, Lidija
    Gnant, Michael
    Thaler, Josef
    ANTICANCER RESEARCH, 2017, 37 (05) : 2683 - 2691
  • [50] Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: Response to the local treatment after chemoradiation and surgery as secondary endpoint
    Schmoll, H-J
    Price, T.
    Haustermanns, K.
    Nordlinger, B.
    Hofheinz, R-D
    Daisne, J-F
    Janssens, J.
    Schmidt, P.
    Reinel, H.
    van Cutsem, E.
    ONKOLOGIE, 2013, 36 : 103 - 103
12345